| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |